Triclosan Inhibition of Prostaglandin Production in Human Gingival Fibroblast |
Park, Seong-Pyu
(Dept. of Periodontology, College of Dentistry and Dental Science Research Institute, Chonnam National University)
Chung, Hyun-Ju (Dept. of Periodontology, College of Dentistry and Dental Science Research Institute, Chonnam National University) Kim, Young-Joon (Dept. of Periodontology, College of Dentistry and Dental Science Research Institute, Chonnam National University) Kim, Ok-Su (Dept. of Periodontology, College of Dentistry and Dental Science Research Institute, Chonnam National University) |
1 | Gillett R, Johnson NW: Bacterial invasion of the periodontium in a case of juvenile periodontitis. J Clin Periodontol 9:93-101, 1982 |
2 | Richads D, Rutherford RB: The effect of interleukin-1 on collagenolytic activity and prostaglandin E secretion by human periodontal ligament and gingival fibroblast. Archs Oral Biol 33:237-243, 1988 |
3 | Regos J, Zak O, Solf R,Vischer WA, Weirich EG: Antimicrobial spectrum of triclosan, a broad spectrum antimicrobial agent for topical application II. Comparison with some other antimicrobial agents. Dermatologica 158:72-79, 1978 |
4 | Kjarheim V, Barkvoll P, Waaler SM, Rolla G: Triclosan inhibits histamin-induced inflammation in human skin. J Clin Periodontol 22:423-426, 1995 |
5 | Modeer T, Bengtsson A, Rolla G: Triclosan reduces prostaglandin biosynthesis in human gingival fibroblasts challenged with interleukin-1 in vitro. J Clio Periodontol 23:927-933, 1996 |
6 | Bevilacqua MP, Pober JS, Wheeler ME, Cotran RS, Gimbrone MA Jr: Interleukin-l acts on cultured human vascular endothelium to increase the adhesion of polymorphoneuclear leukocytes, monocytes and related leukocyte cell lines. J Clin Invest 76:2003-2011, 1985 |
7 | Vane JR, Bakhle YS, Bottling RM: Cydooxygenase 1 and 2. Annu Rev Pharmacol Toxicol 38:97-120, 1998. DOI ScienceOn |
8 | Kargman S, Charleson S, Cartwright M, Frank J, Reindeau D: Characterization of prostaglandin G/H synthase 1 and 2 in rat, dog, monkey and human gastrointestinal tracts. Gastroenterol 111:445-454,1996 |
9 | Kawaguchi H, Pilbeam C, Harrison J, Raisz L: The role of prostaglandins, in the regulation of bone metabolism. Clin Orthop Relat Res. 313:36-46, 1995 |
10 | Bezerra M, lima V, Alenear V, Vieira I, Brito G, Ribeiro R, Rocha A: Selective cydooxygenase-2 inhibition prevents alveolar bone loss in experimental periodontitis in rats. J Periodontol 71:1009-1014,2000 |
11 | Harrison TR: In: Harrison's principles of internal medicine (Wilson JD, Braunwald E, Isselbacher KJ, Petersdorf RG, ed.). pp1543-. New York: McGraw Hill, 1994 |
12 | Zuckerbram HL, Babich H, May RJ, Sinensky MC: Tridosan; cytotoxicity, mode of action, and induction of apoptosis in human gingival cells in vitro. Eur J Oral Sci 106:628-636, 1998 |
13 | Offenbacher S, Heasman PA, Collins JG: Modulation of host secretion as a determinant of periodontal disease expression. J Periodontol 64:432-444, 1993 |
14 | Futaki N, Arai I, Hamasaka Y, Takahasi S, Higuchi S, Otomo S: Selective inhibition of NS 398 on prostanoid productionin inflamed tissue in rat carrageenan-air-pouch inflammation. J Pharm Pharmacol 45:753-755, 1993 |
15 | Waaler SM, Rollar G, Skjorland KK, Ogaard B: Effects of oral rinsing with triclosan and sodium lauryl sulfate on dental plaque formation: a pilot study. Scand J Dent Res, 101:192-195, 1993 |
16 | Gaffar A, Aftlitto J, Nabi N, Kruger J, Olsen S: Recent advances in plaque, gingivitis, tartar and caries prevention technology. Int Dent J 44:63-70,1994 |
17 | Skaare AB, Kjarheim V, Barkvoll P, Rolla G: Does the nature of solvent affect the anti-inflamatory capacity of triclosan? An experimental study. J Clin Periodontol 24:124-128, 1997 |
18 | Futaki N, Takahasi S, Yokoyama M,Yamakawa Y, Arai I, Higuchi S, Otomo S: NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins 47:55-59,1995 |
19 | Cox AR: Efficacy of the antimicrobial agent triclosan in topical deodorant products: recent development in vivo. J Soc Cosmet Chem 38:223-231, 1987 |
20 | Chen C, Sun Y, Chen J, Chang Y: TNF- induced cydooxygenase-2 expression via sequential activation of ceramide-dependent mitogen activated protein kinase, and I I B kinase 1/2 in human alveolar epithelial cells. Mol Pharmacol 59:493-500, 2001 |
21 | Golden BD, Abramson SB: selective cyclooxygenase-2 inhibitor. Rheumatic Dis Clin NorthAme 25:359-378, 1999 |
22 | Birkedal-Hansen H: Role of cytokines and inflammatory mediators in tissue destruction. J Periodont Res 28:500-510, 1993 |
23 | Kjarheim V, Skaare A, Barkvoll P, Rolla G: Antiplaque, antibacterial and anti-inflammatory properties of triclosan mouthrinses in combination with zinc citrate or polyvinylmethylether maleic acid (PMV-MA) copolymer. Eur J Oral Sci 104:529-534, 1996 |
24 | Masada MP, Kenney JS, Lee RC, Allison AC: The effects of interleukin -1 and 6 in gingival crevicular fluid implication for the pathogenesis of periodontal disease. J Periodontal Res 25:156-163, 1990 |
25 | Black JG, Howe D, Rutherford T: Percutaneous absorption and metabolism of Irgasan DP 300. Toxicology 3:33-47,1975 |
26 | Ouillet Mand Percival MD: Effect of inhibitor time-dependency on selectivity towards cydooxygenase isoforms, Biochem J 306:247-251,1995 |
27 | Offenbacher S,Williams RC,Jeffcoat MK, Howell TH, Odle BM, Smith MA, Hall CM,Johnson HG, Goldhaber P: Effects of NSAIDs on beagle crevicular cydooxygenase metabolites and periodontal bone loss. J Periodont Res 27:207-213, 1992 |
28 | Wallace JL: Distribution and expression of cydooxygenase (COX) isoenzymes, their physiological roles, and the categorization of nonsteroidal anti-inflammatory drugs (NSAIDs). Am J Med107(6A):115-17S, 1999 |
29 | Futaki N, Yoshikawa K, Hamasaka Y, Arai I, Higuchi S, Iizuka H, Otomo S: NS-398, a novel non-steroidal anti-inflammatory drug with potent analgesic and antipyretic effects, which causes minimal stomach lesion. Gen Pharmacol 24:105-110,1993 |
30 | Sismey-Durrant HJ, Hopps RM: Effect of lipopolysaccharide from Porphyromonas gingivalis on prostaglandin E2 and interleukin-1 release from rat periosteal and human gingival fibroblasts in vitro. Oral Microbiol Immunol 6: 378-380, 1991 |
31 | Bevilacqua MP, Pober JS, Mendrlck DL, Cotran RS, Gimbrone MA: Identification of an inducible endothelial leukocyte adhesion molecule. Proc Natl Acad Sci U.S.A. 84:9238-9242, 1987 |
32 | Saglie R, Newman MG, Carranza Jr, FA, Pattison GL: Bacterial invasion of advanced periodontitis in humans.J Periodontol 53: 217-222, 1982 |
33 | Yucel-Lindberg T, Ahola H, Carlsstedt-Duke J, Modeer T: Involvement of tyrosin kinases on cyclooxygenase expression and prostaglandin production in human gingival fibroblasts stimulated with interleukin -1 and epidermal growth factor. Biochem Biophys Res Commun 257:528-532,1999 |
34 | Ebersole JL, Singer RE, Steffensen B, Filloon T, Korman KS: Inflammatory mediators and immunoglobulins in GCF fromhealthy, gingivitis and periodontal sites. J Periodont Res 28:543-546,1993 |
35 | Gaffar A, Scherl D, Aftlitto J, Coleman EJ: The effect of triclosan on mediators of gingival inflammation. J Clin Periodontol 22:480-484, 1995 |
36 | Takada H, Mihara I, Morisaki K, Hamada K: Induction of interleukin-1 and -6 in human gingival fibroblast cultures stimulated by bacteroides lipopolysaccharides. Infect Immun 59:295-301, 1991 |